Stearic Acid

Stearic Acid

SCHEMBL5487757

[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117915958-A Dendritic structures as non-viral vectors in gene delivery 蒂巴生物技术有限公司 2024-04-19 CN disclosed
WO-2015085411-A1 MODULATION OF THE BETA-OXIDATION PATHWAY IN THE CONTROL OF RHAMNOLIPID PRODUCTION INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) 2015-06-18 WO disclosed
US-20070123695-A1 a gravitational, centrifugal, magnetic,= or an electric field force to the starting molecules causing them to move in space and then chemically react to form tailored assemblies of molecules in a particular pattern in a nanoscale size macroscopic film for removal and subsequent use; nanotechnology UNITED STATES DEPARTMENT OF ENERGY 2007-05-31 US disclosed
US-6503478-B2 Administering deuderated compound; spectrum analysis; applying electromagnetic waves, scanning LIGHTOUCH MEDICAL, INC. 2003-01-07 US disclosed
US-20020041848-A1 Administering deuderated compound; spectrum analysis; applying electromagnetic waves, scanning AVALYRA INC. 2002-04-11 US disclosed
WO-2001051094-A1 DIAGNOSTIC METHOD USING A DEUTERATED AGENT FOR IMAGING SPECIFIC TISSUE LIGHTOUCH MEDICAL, INC. (US) 2001-07-19 WO disclosed